(Q45975517)

English

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

author name string

S H Ralston

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

M D Gardner

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

F J Dryburgh

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

A S Jenkins

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

R A Cowan

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

I T Boyle

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

language of work or name

0 references

publication date

1 October 1985

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

8461

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

907-910

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

Treatment of hypercalcemia. Comparison of intravenously administered phosphate, sulfate, and hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mithramycin treatment of hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of two parenteral diphosphonates in hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hypercalcaemia associated with malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of malignancy-associated hypercalcemia: 1983

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of available medical therapy for hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive value of derived calcium figures based on the measurement of ionised calcium.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The hypercalcemia of malignancy: pathogenesis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of glucocorticoids in management of malignant hypercalcaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990848-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(85)90848-7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2865417

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45975517&oldid=1399396979"